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Abstract
Aim: To examine the role of IgA, CIC and component C3 as indicators of humoral immune response
in the etiopathogenesis of oral erosive lichen planus (OELP).
Material and method: The study comprised 19 patients with OELP whose samples of blood, saliva
and tissue were obtained after carefully taken medical history and clinical examination. Samples of
oral mucosa were taken from the site of lesion, i.e. exclusively from buccal mucosa (1 cm in width
and length), and from the deep epithelium as well as a segment from the lamina propria.
Determination of immunoglobulins in serum and saliva, and determination of component C3, was
done using the micro-elisa technique by Rook&Cameron, Engvall and Ulman. Determination of CIC
in serum and mixed saliva was done with the PEG (polyethylene glycol) method. Determination of
immunoglobulin A and component C3 in biopsy material was done with direct immunofluorescence.
Results: Levels of immunoglobulin A in serum in OELP during exacerbation were decreased (1.04 ±
0.49 gr/l) and during remission increased (5.92 ± 0.62) in comparison with the control group (p <
0.001). Levels of CIC during exacerbation and remission were increased (p < 0.001), and component
C3 levels were increased in both examined phases in the examined group compared with the control
group (p < 0.05). Deposits of IgA were registered in one (5.88%) patient with OELP and component
C3 was registered in 3 (17.64%) patients.
Conclusion: Changes in IgA values, as well as CIC and component C3, may correlate with changes in
oral mucosa emphasizing the role of humoral immune response in the pathogenesis of oral lichen planus.
Key words: erosive lichen planus, humoral immunity, immunoglobulin A, CIC, component C3.
Introduction
The etiology of lichen planus is still not
well established, but it has been confirmed that
different causes participate in its pathogenesis [1,
2]. It is believed that immunologic mechanisms
are involved as one of the potential factors in the
pathogenesis of this common disease [1–3].
The immunological ground is one of the
priority mechanisms in the multicausal patho-
genesis of oral lichen planus in which immu-
noglobulins [4, 5] and autoantibodies [6–9]
play the key roles. Literature reports related to
this issue differ. Some studies have presented
increased [4, 5, 8, 10, 11], reduced [11, 12] or
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even normal [13–15] immunoglobulin fractions
in patients with oral lichen planus.
Immunoglobulins are glycoproteins, which
are expressed as membrane receptors on the
surface of B-cells or as soluble molecules se-
creting B-cells [16]. In normal serum immuno-
globulin G is found in 70–75% or 1000 mg/dl
[17], followed by IgA accounting for 15–20%
or 200 mg/dl [1]. The situation is quite the op-
posite in saliva, the level of immunoglobulin G
is reduced and reaches a maximum 2–3 mg/dl,
and the IgA level is increased and is around
10–20 mg/dl [18].
Sistig [19] says that salivary immunoglo-
bulin levels may play a role in the pathogenesis
of oral mucosal diseases, including lichen pla-
nus, or that they reflect clinical changes in
these conditions. With reference to this issue,
an increased level of serum IgA and IgG in
patients with OLP has been found [20, 21].
Ghaliani [22] showed significant differen-
ces in the distribution of IgG + cells in different
sites of oral lichen planus or lichenoid lesions
separately, but there was no significant differ-
rence in the distribution of IgG + cells between
oral lichen planus and lichenoid lesions. Altr-
hough Sistig [19] demonstrated an increased ler-
vel of salivary IgA and IgG in these patients, Van
der Waal [23] did not confirm that assumption.
These facts have motivated us to set the
aim of our study: to determine the role of IgA,
CIC and complement C3 as indicators of hu-
moral immune response in the etiopathogenesis
of oral erosive lichen planus (OELP) by their
monitoring in serum and saliva during exacer-
bation and remission phases as well as in tissue
samples taken from the affected site.
Material and method
The study included 19 patients of diffent
sex and age, diagnosed with oral lichen planus
on buccal mucosa, who were treated according
to the guidelines of the Mouth and Periodontal
Diseases Clinic of the Faculty of Dentistry in
Skopje and also the Ethics Committee. The
study did not include patients with cutaneous
manifestation and those who, in addition to
cutaneous manifestation, had oral maniestation.
Diagnosis was made on the basis of thorough
history, objective clinical findings and pathohis-
tological verification in the biopsy specimen.
In addition to a careful medical history
and clinical examination, serum, saliva and tis-
sue samples were taken from each patient.
Blood was drawn at the Institute of Transfusion
Medicine with venipuncture from the cubital
vein adding an anticoagulation agent in sterile
tubes.
Unstimulated 5 to 10 ccm morning saliva
was collected at the Clinic of Mouth and Perio-
dontal Diseases. Two hours after the samples
were taken, the material was sent to the Insti-
tute of Transfusion Medicine, where it was fro-
zen until analysed. Oral mucous samples were
obtained by biopsy, which was performed in
sterile conditions, under local anaesthesia. Biop-
sies were taken from the site of the lesion, that
is, exclusively from buccal mucosa (1 cm in
width and length) and from the deep epithelium
as well as a segment from the lamina propria.
The samples were diluted in sterile PBS and
distributed to the Department of Nephrology
where they were frozen and then analysed.
IgA and component C3 were determined
in patients’ serum, saliva and tissue samples.
CIC was determined only in serum and saliva.
The examinations were done in phases of
exacerbation and remission.
Determination of immunoglobulins in se-
rum and saliva was done with the micro-elisa
technique by Rook & Cameron, Engvall and
Ulman.
Determination of component C3 in saliva
was done with the same method as that for im-
munoglobulins, the difference being in the par-
tigen plates used, coated with specific antibo-
dies for these components. Normal serum va-
lues for C3 are 0.80–1.40 gr/l, and for C4 0.2–
0.5 gr/l.
Determination of CIC in serum and mi-
xed saliva was done with the PEG (polyethy-
lene glycol) method.
Determination of IgA and component C3
in biopsy specimens was done with direct im-
munofluorescence.
The tissue was frozen at -280 in cryocut,
and then cut. Samples were dried for 30 minu-
tes at room temperature. Thirty minutes later
they were put in cuvettes with a cold acetone
where they were kept for 10 minutes; when
rabbit serum is prepared in acetone diluted with
PBS (NaCl 29.2 gr + NaHPO4 H2O 2.5 gr +
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NaHPO4 7H2O – 14.5 ratio for the solution of
4l) in 1: 5 ratio. 100 µl serum and 500 ml PBS
are taken and kept in tubes. Following this pro-
cedure, samples are placed in a humid cham-
ber, a drop of rabbit antiserum is poured in; the
tissue is covered and is left in a humid chamber
for 10 minutes. While samples are in the cham-
ber, sera are diluted.
For determination of IgA 5 µl serum and
250 ml PBS are taken. Ten minutes later the ex-
cess rabbit serum is removed from the samples,
but they have to be kept humid; then, a drop of
the relevant antiserum with monoclonal antibo-
dies is added to each sample; the tissue is covered
and left in a humid chamber for 90 minutes.
Anti-mouse peroxidase conjugate (prepa-
red serum) in a volume of 20 µl is added and
diluted with 800 ml PBS. 40 µl of human se-
rum is added to the diluted serum. Serum is
prepared in the phase of washing the samples.
Samples are washed with PBS in cuvettes
twice in two minutes. They are dried, carefully
mopped and put in a humid chamber.
A drop of the prepared anti-mouse pero-
xidase conjugate is poured on each sample so
that they are well covered and are left in a hu-
mid chamber for 30 minutes. Then, they are
washed with PBS three times for 3 minutes. In
the meantime, a 5 mgr solution of diaminoben-
zidine is prepared in a tube with 10 ml PBS.
The test-tube is well mixed and in another tube
3 drops of 3% H2O2 are added. These two mi-
xtures are combined and mixed. A drop of this
mixture is poured on the samples and they are
left in a humid chamber for 1 to 2 minutes.
Diaminobenzidine is removed from the sam-
ples; they are again placed in PBS and are
washed; then they are put in hematoxylin for
0.5 to 2 minutes; they are washed with water
several times for 2 to 3 minutes. Then they are
kept in 96% alcohol three times for 2 to 3
minutes, then they are put in xylol and finally
they are filtered.
One drop of canada balsam is poured
onto (cover) glass slide and attached to the
slide. The sample is wrung well and carefully
examined under a microscope.
The results obtained were compared with
those of the control group as well as among the
patients during exacerbation and remission pe-
riods.
The control group consisted of 224 heal-
thy subjects from the Institute of Transfusion
Medicine in Skopje who did not suffer from
lichen planus or any other intercurrent illness.
The results of salivary CIC and IgA
levels were used for comparison with a control
group of 25 subjects who did not suffer from
lichen planus or any other intercurrent illness.
The results obtained for the levels of C3
in serum in the control group from the Institute
of Transfusion Medicine were used for com-
parison.
All results were compared with the con-
trol group and among the patients in the phases
of exacerbation and remission.
The results were statistically analysed by
using the Student’s t-test for significance in
differences.
Results
Statistical analyses of the values of IgA
in serum in OELP during exacerbation showed
decreased levels (1.04 ± 0.62) and during re-
mission increased levels (5.92 ± 0.62) in com-
parison with the control group, resulting in
both cases in highly significant differences (p <
0.001). CIC values in exacerbation and remis-
sion were increased (p < 0.001). C3 values were
slightly increased in both examined phases in
our groups of examinees and controls (p < 0.05)
(Table 1).
Table 1
Serum levels of IgA, CIC and component C3 in examined and control groups during exacerbation and remission
Control group Examined group
Exacerbation Remission
gr/l IgA CIC C3 IgA CIC C3 IgA CIC C3
 2.70 0.05 0.65 1.04 0.14 0.90 5.92 0.11 0.75
SD 0.63 0.02 0.14 0.49 0.09 0.13 0.62 0.04 0.17
Se 0.04 0.001 0.02 0.11 0.02 0.02 0.14 0.009 0.03
t 11.15 11.84 2.73 21.33 11.25 2.08
p < 0.001 0.001 0.05 0.001 0.001 0.05
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Salivary IgA levels in oral erosive lichen
planus during exacerbation and remission pha-
ses varied identically as in serum (p < 0.001).
CIC values during exacerbation and remission
were increased compared to the control group
(p < 0.001). CIC values showed an increase in
both phases in the examined compared with the
control group (p < 0.001), and C3 showed a
more dramatic decline during exacerbation (p <
0.001) and moderate decline during remission
(p < 0.05) (Table 2).
Table 2
Salivary IgA, CIC and component C3 levels in examined and control groups during exacerbation and remission
Control group Examined group
Exacerbation Remission
gr/l IgA CIC C3 IgA CIC C3 IgA CIC C3
 1.10 0.02 0.76 0.71 0.09 0.28 2.42 0.04 0.57
SD 0.01 0.01 0.23 0.31 0.03 0.09 0.09 0.02 0.19
Se 0.002 0.002 0.004 0.007 0.006 0.02 0.02 0.004 0.04
t 6.14 10.64 8.41 13.20 4.23 2.35
p < 0.001 0.001 0.001 0.001 0.001 0.05
Table 3 presents tissue distribution of
IgA and component C3 in both controls and
examinees. At the basement membrane no de-
posits of IgA and component C3 were found in
the control group; IgA deposits were found in
one (5.88%) of the examined subjects, and
complement C3 was found in 3 (17.65%) pa-
tients (Figs. 1 and 2).
Table 3
Tissue distribution of IgA and component C3 in control group and bullous oral lichen planus
Control group
n = 14
Examined group
n = 17
n % n %
IgA 0 0 1 5.88
C3 0 0 3 17.64
Figure 1 – Deposits of IgA at the epithelial basement
membrane and the most superficial layer of lamina
propria in OELP
Figure 2 – Deposits of component C3
at the basement membrane, suprabasement in tissue
specimens of OELP
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Discussion
Immunoglobulins are carriers of humoral
immunity, and hence every increased or redu-
ced value of certain groups of proteins is an in-
dicator not only of the existence of some mor-
bid process, but also of the degree of its acti-
vity, no matter what its location and specificity.
Regarding this, Sklavounou [24] pointed
out a significant reduction of all immunoglo-
bulin fractions, including IgA in serum. Exami-
ning a quite small number of cases, Stankler
[25] concluded that there was a significant lo-
wering in the levels of both IgA and IgM. Con-
trary to these findings, Biocina-Lukenda [26]
documented increased serum levels of IgA and
IgM in oral lichen planus, suggesting that hu-
moral immunity participated in the pathogene-
sis of oral lichen planus.
Jacyk and Greenwood [27], in an attempt
to test the findings of Stankler [25], observed a
significant decrease only in the IgM level, whe-
reas they found no quantitative deviation in the
remaining immunoglobulin fractions.
Cerni and Griffith [28–29] reported nor-
mal levels of all immunoglobulins, including
IgA, as well as of component C3.
Our findings have revealed a significant
decrease of IgA in serum during exacerbation
in comparison with the control group (p < 0.001).
This result is partially in agreement with the
findings of some authors [2, 5, 25, 27], and the
opposite of the findings of other authors [29].
With reference to the values of this immuno-
globulin in the phase of remission, we observed
an increase in the examinees compared to the
controls (p > 0.001).
Sallay [30] emphasizes that a subepithe-
lial mononuclear reaction is a special characte-
ristic of lichen, and that it is aimed at the epit-
helial cells leading to destructive zones in the
affected surfaces. Identified deposits of immu-
noglobulin, complement, fibrinogen and CIC in
the lichen planus lesions enter through circu-
lation [31]. Chatterjee [32] observed markedly
higher CIC mean values in several complicated
oral hyperkeratosis, such as leukoplakia, epit-
helial dysplasia and oral carcinoma. This aut-
hor claims that CIC in the tissue originates
from the circulation and is a result of some pat-
hologic conditions in the organism. The hypo-
thesis of Chatterjee [32] is in contrast to the
findings of Weksler [33].
Association of free humoral antibodies in
CIC might be induced by various diseases,
especially diabetes mellitus or hypertension,
that is, the so-called Grinspan’s syndrome. Thus
it is logical that high serum levels of CIC are
present in this group of patients [32].
This conclusion coincides with Weksler’s
observation [33]; he states that any deviation in
terms of elevated or reduced CIC serum con-
centration is not a reflection of some morbid
process in the organism, but rather of physiolo-
gical variations that go parallel with ageing.
Sallay [30] found an increased frequency of
CIC positivity in str. granulosum and str. spi-
nosum in biopsy specimens of lichen lesions.
Within this context Banoczy [34] obser-
ved an increased frequency of CIC positivity
not only in oral lichen planus, but in oral leuko-
plakia and oral carcinoma as well. According
to this author, this parameter points to the pos-
sibility that CIC positivity, both in serum and
in tissue, in patients with oral lichen planus and
leukoplakia, is an indicator of an eventual ma-
lignant transformation of these diseases.
In our examined group the CIC level in
serum during exacerbation and remission was
increased in comparison with the level in the
control group (p < 0.001).
Our results obtained for the CIC levels
are identical with those reported by some other
studies [30, 32, 34] and are in contrast with the
findings of Weksler [33].
The complement is one of the major hu-
moral effector mechanisms of particular impor-
tance. Tissue disorders are usually destructive
changes caused by immune complexes. Defi-
ciency or hyperproduction of some of the com-
ponents might result in the development of
some disease [35]. Not observing any changes
in the component C3 level, the theory about its
role in the pathogenesis of oral lichen planus
was completely rejected [24, 29, 36].
Our findings obtained for component C3
have shown moderately increased values in exa-
cerbation, and thus there was a small statistical
significance of difference in the values (p < 0.05).
In the remission phase the level of component
C3 was decreased as opposed to the exacer-
bation phase (0.75 ± 0.17 gr/l). As we have
already mentioned, in our examined subjects in
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the phase of disease exacerbation there was a
reduced serum level of IgA and an increased
level of CIC. We think that these low levels of
serum IgA and concomitant increase of CIC are
due to their incorporation into the CIC. CIC,
which is associated with IgA, which activates
the complement in an alternative way. The high
CIC level in this phase of the disease indicates
an activated humoral response by including the
complementary system as a major mediator in
the antigen-antibody reactions. We can explain
the obtained high levels of component C3 in
this phase of the disease with the emphasised
and indisputable role of the complementary
system in the etiopathogenesis of oral lichen
planus.
The results of our examination in the
remission phase showed an increased serum
IgA. CIC was also increased and component C3
was moderately decreased in comparison with
the phase of exacerbation, but still higher than
the results in the control group.
It is known that oral lichen planus is a
disease that persists throughout the lifespan in
the majority of cases, with occasional exacer-
bations or spontaneous and therapeutic impro-
vement, and with shorter or longer remission
periods. Therefore, the opinion of many oral
pathologists is justified concerning the need for
a certain antigen, of unknown origin at present,
which would stimulate or inhibit the immuno-
logic response of the organism.
In the phase of remission in patients with
the erosive form there is epithelization of the
previously present erosive or erosive-ulcerous
surfaces, with or without minimum signs of in-
flammation and improved general subjective
symptoms. Stabilization of the immune status
in this phase of the disease was manifested by
an increase of the immunoglobulin fraction in
our group of patients. The factor (antigen) that
stimulates the immune system is most probably
present somewhere in the organism, but provo-
cation that will activate it is necessary and will
cause the phase of exacerbation. The present
immunoglobulins in the circulation during re-
entry of the antigen will join the antigens and
will create CIC by incorporating the compo-
nent C3. This, in fact, explains the high levels
of CIC and reduced levels of component C3 in
the remission phase as opposed to the exacer-
bation phase.
One of the numerous functions of the
complement is cell lysis, which is being reali-
zed through complement components C8 and
C9. This action is performed by the comple-
ment which binds the component C3 and later
all other components, which is reflected by a
decreased level of component C3 in the phase
of remission.
The results obtained in our group of pa-
tients in the phase of disease exacerbation have
shown reduced salivary IgA levels (0.71 ± 0.31
gr/l) as opposed to the results in the control
group (1.10 ± 0.01 gr/l), and hence the diffe-
rence between them was statistically significant
(p < 0.001). It has been proven experimentally
and theoretically that IgA is the major protein
with a protective function, which is in direct
relation with the defence mechanism of the oral
mucosa. We can explain the reduced levels of
this immunoglobulin with the reduced resis-
tance of oral mucosa to numerous exogenous
and endogenous factors that attack it frequently
and induce certain pathological conditions ma-
nifested with possible classic, benign and even
erosive-ulcerous lesions, with a very dramatic
clinical picture and even possible malignant al-
teration. In the phase of exacerbation this im-
munoglobulin is created to a certain extent
from the serum or as a result of its local synthe-
sis in the salivary glands. However, the ability
of this immunoglobulin to activate the comple-
ment as well as to bind with the antigen-stimu-
lator, to incorporate in CIC with the saliva,
leads to reduced salivary levels of the C3 that is
incorporated into this complex. This is how we
interpret our results that are characteristic for
this phase of the disease. If we add the ability
of this immunoglobulin to increase the phago-
cytic activity of macrophages and to have an
indirect bacteriolytic effect, which is realized in
the presence of the complement and lysozime,
then the low levels of component C3 obtained
in our investigation were to be expected. One
part of IgA from the mixed saliva is bound to
the mucin-creating precipitating cover that is
"the first line of defense", which in a certain
way incorporates this immunoglobulin and
hence accomplishes one of its basic functions –
a bioprotective one. This is also an explanation
of the results we have obtained.
We observed an increase of IgA in the
phase of remission in patients with OELP. The
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difference between the examined and control
groups was highly significant (p < 0.001). We
can explain the increased salivary IgA levels in
the remission phase with strengthening the ge-
neral immunological status of the organism,
which has some effect on the local defence
capability of the oral mucosa and which is ref-
lected in the objective and subjective improve-
ment of the clinical presentation of the disease
in all clinical forms of oral lichen planus.
Sistig et al. [37] did not define difference
between exacerbation and remission, but they
found increased salivary levels of IgA in oral
lichen planus.
It is known that IgA is the key antibody
in all secretions, including saliva, and it is com-
pletely responsible for realization of the de-
fence mechanisms of mucous surfaces. Altho-
ugh in this context the priority is given to this
immunoglobulin, the other carriers of humoral
immunity are not to be neglected.
The analysis of CIC in exacerbation and
remission revealed an increased level in com-
parison with the control group, and a decreased
level of component C3 in the examined group.
Numerous former morphological studies
have provided only limited information on the
nature of this disease. In the beginning the
changes in the epithelium were pointed out as
crucial and responsible for the pathogenic
events, with a special accent on the degenera-
tive changes of the basal cells [38–39].
Walker [41] examined the immunologi-
cal markers in the lesions of mucous membrane
in patients with lichen planus and identified
only a few cells in the infiltrate that belonged
to B-cells or macrophages. He proved that T-cell
subpopulations were predominant in the lichen
planus infiltrate.
Identical results were presented by Abell
[41] and Tuffanelli [42]. They consider humo-
ral immune system or B-cells to play a smaller
role in the development of this disease. Rarely
found B-cells in the infiltrate are a confirma-
tion of their results.
The concept that humoral immunity is
not of crucial importance in the pathogenic
sense has been supported by the latest investi-
gations and knowledge that speak in favour of
the fact that B-cells are found in infiltrates and
these are precursors of cell creating antibodies.
However, Yanossy [43] identified only a mini-
mum synthesis of the immunoglobulins in the
biopsy specimens compared to other diseases
but, on the other hand, lymphocytes and histio-
cytes were predominant.
Applying the immunofluorescent techni-
que for detection of deposits of IgG, IgM, IgA
and component C3, and fibrinogen at the base-
ment membrane in lichen planus lesions,
Schiodt [31] confirmed that tissue distribution
of immunoglobulins is not typical for lichen
planus lesions, although this author adds a pos-
sible diagnostic or differential diagnostic im-
portance to these deposits. Component C3 fre-
quently appears in other oral lesions, diame-
trically different from oral lichen planus, and
according to Schiodt it is not pathognomic for
this disease.
Frequency, distribution and morphology
of the deposits of immunoglobulins, compo-
nent C3 and fibrinogen in oral lesions and cli-
nically normal oral mucosa were in accordance
with the skin findings in the Konrad’s investi-
gation [44]. The findings coincided with pre-
vious examinations of the skin and oral mu-
cosa. It is believed that not only the presence of
deposits of immunoglobulins is important, but
also frequency of immunoglobulin deposits at
the basement membrane as well. A significant
difference was discovered between discoid le-
sions on one side and oral lichen planus on the
other [31].
Laskaris [46] observed deposition of IgA,
IgG and IgM, but there were no cases with
component C3. In spite of the presence of these
proteins, the author thinks these findings have
no diagnostic significance although sometimes
they might be useful in the diagnostics of the
disease.
Daniels [46] retrospectively analysed di-
rect immunofluorescence findings in several
dermatoses including lichen planus, and he no-
ticed no positive fluorescent patterns with anti-
Ig or anti-C3 complement in any samples. Con-
trary to this author, some other authors [47–50]
discovered deposits of IgA, IgG and IgM in
oral lichen planus.
In the biopsy material of our examined
subjects comprising patients with erosive form
of lichen planus, deposits of immunoglobulins
at the basement membrane were found. Depo-
sits of immunoglobulin A were found in one of
the 17 subjects or in 5.88%. Component C3
was found in 3 patients or in 17.64%.
Our results coincide with other reports
[47, 48, 50] and are contrary to some others
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[38, 39, 41, 42]. Many of the local inflamma-
tory cells in the infiltrate of the oral lichen
planus lesions were the immunocompetent T-
lymphocytes, which findings are in line with
other authors [51–54]. Therefore, a hypothesis
has been proposed about the interaction bet-
ween cellular and molecular signals in the local
immune response. It is based on mast cell de-
granulation and changes in the blood vessels
endothelium, which support the lymphocytic
attachment to the tissue. Cytokine production
by the lymphocytes has a direct influence on
local immune response, but also on disease
chronicity [51].
Changes in the IgA levels on all examined
media, as well as of CIC and component C3, may
correlate with the changes of oral mucosa emp-
hasizing the role of humoral immune response in
the pathogenesis of oral lichen planus.
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Цел. Да го истражиме учеството на ИгА,
ЦИК и компонентата Ц3 како индикатори на
хуморалниот имун одговор во етиопатогенезата
на оралниот ерозивен лихен планус (ОЕЛП).
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пациенти од различен пол и возраст, со ОЕЛП,
кај кои подетално земената анамнеза и
клиничкиот преглед, се земени крв, плунка и
ткивен исечок. Крвта е земана во Заводот за
трансфузиологија, со венепункција од куби-
талната вена, а плунката е собирана наутро по
пат на просто прелевање, без стимулација во
количина од 5 до 10 ccm. Исечоците од оралната
лигавица се земани од местото на лезијата, т.е.
исклучиво од образната лигавица (1 cm во
ширина и должина), а во длабочина е опфатен
епителот во целост и голем дел од крзното.
Понатаму, исечокот е ставан во стерилен р-р
PBS, дистрибуиран, замрзнуван, а потоа и
обработуван.
Одредување на имуноглобулините во се-
рум и плунка е спроведено со помош на техника
микроелиса според Rook & Cameron, Engvall
and Ulman.
Определувањето на Ц3-компонентата на
комплементот во плунка е спроведено со иста
метода како и за имуноглобулините, само што
овде во партиген плочите има и специфични
антитела за овие компоненти. Определувањето
на ЦИК во серум и мешана плунка е изведувано
според методата на PEG (полиетолен гликол).
Определување на имуноглобулин А и
компонентата Ц3 на комплементот во
биоптичен материјал е изведено со директна
имунофлуоресценција.
Кај сите пациенти се одредувани имуно-
глобулинот А и компонентата на комплементот
Ц3 во серум, плунка и ткивен исечок. ЦИК е
одредуван само во серум и плунка.
Испитувањата се реализирани во фаза на
егзацербација и ремисија.
Резултатите се статистички обработени,
преку примена на студентовиот "t"-тест.
Резултати. Вредностите на имуноглобу-
лин А во серум кај ОЕЛП при егзацербација се
намалени (1,04 ± 0,49 gr/l), а во ремисија
зголемени (5,92 ± 0,62) во споредба со
контролната група (p < 0,001). Вредностите на
ЦИК во егзацербација и ремисија се зголемени
(p < 0,001), а компонентата Ц3 покажува пораст
во двете испитувани фази кај испитуваната
наспроти контролната група, но p < 0,05.
Саливарните вредности на имуноглобулин А кај
ОЕЛП при егзацербација и ремисија варираат
идентично како во серум p < 0,001. Вредностите
на ЦИК во егзацербација и ремисија се
зголемени (p < 0,001), a Ц3 e со подрастичен пад
при егзацебацијата (p < 0,001) и поумерено
намалување при ремисијата (p < 0,05) во
споредба со контролната група.
Кај групата испитаници со ОЕЛП се еви-
дентирани депозити од ИгА кај еден испитаник,
т.е. 5,88%, а Ц3-компонентата на комплементот
е застапена кај тројца болни, односно 17 т.е.
64%.
Заклучок. Промените на вредностите на
ИгА во сите испитувани медиуми, како и ЦИК и
компонентата Ц3 на комплементот може да
корелираат со промените на оралната мукоза,
потенцирајќи ја улогата на хуморалниот имун
одговор во патогенезата на оралниот лихен
планус.
Клучни зборови: ерозивен лихен планус, хуморален
имунитет, имуноглобулин А, ЦИК, компонента Ц3
на комплемент.
